British American Tobacco Résultats passés
Passé contrôle des critères 0/6
Les bénéfices de British American Tobacco ont diminué à un taux annuel moyen de -41.4%, tandis que le secteur Tobacco a vu ses bénéfices augmenter de en à 9.5% par an. Les revenus ont augmenté de en à un taux moyen de 1.7% par an.
Informations clés
-41.4%
Taux de croissance des bénéfices
-41.5%
Taux de croissance du BPA
Tobacco Croissance de l'industrie | 18.1% |
Taux de croissance des recettes | 1.7% |
Rendement des fonds propres | -25.1% |
Marge nette | -53.0% |
Prochaine mise à jour des résultats | 13 Feb 2025 |
Mises à jour récentes des performances passées
Recent updates
British American: 3 Reasons I'm Buying This 8.2% Yielding Aristocrat In 2025
Nov 20British American Tobacco: Fairly Priced Despite 7.5x P/E
Nov 14British American Tobacco: Bargain Entry Into A Shifting Market
Oct 313 Reasons British American Tobacco Remains A Buy
Oct 25British American Tobacco: Still A Solid Income Play
Oct 04British American Tobacco Yields ~8%, But Total Shareholder Yield Could Be 10%+
Sep 24British American Tobacco: Shares Still A Bargain After The Mid-Year Rally
Sep 17British American Tobacco: Called The Surge, Staying Invested
Aug 24British American Tobacco: New Categories Segment Shows Promise
Aug 17British American Tobacco: Reassessing My Hold Rating After July's Surge (Rating Upgrade)
Aug 06British American Tobacco Is Making A Comeback Against All Odds
Jul 25British American Tobacco: Let's Ask Benjamin Graham
Jul 10British American Tobacco: Fighting An Uphill Battle
Jun 15British American Tobacco: Still Not Worth Investing
Jun 05British American Tobacco: The Window To Buy And Lock In This 9.5% Yield Might Be Closing
May 29Tidefall Capital - British American Tobacco: Success Against Illegal Chinese Vapes Would Immediately Be A Major Tailwind
May 17British American Tobacco Isn't Dead Money As Pessimism Peaks
May 08British American Tobacco: A 'Hybrid Value' Opportunity
May 02British American Tobacco: The Dividend Yield Is Very Tempting At These Price Levels
Apr 12British American Tobacco: Yielding 9.63% Looks Like An Opportunity Rather Than A Value Trap
Apr 03British American Tobacco: Undervalued With Bearish Assumptions, 10% Dividend
Mar 21British American Tobacco: It's Still A Value Trap, But I'm Lifting My 'Sell' View
Mar 03British American Tobacco: The Worst May Have Already Been Priced In
Feb 19British American Tobacco: Demystifying The Stability Of 9% Dividend
Feb 11Complete Devastation, Massive Income With British American Tobacco
Jan 29Why I'm Avoiding 10%-Yielding British American Tobacco Stock
Jan 17British American Tobacco: No Growth, No Problem - 33% Upside
Dec 17British American Tobacco: What To Make Of The £25 Billion Bombshell
Dec 06British American Tobacco Vs. Altria: Which Is The Better Dividend Choice?
Nov 30British American Tobacco: A Great Play In The Tobacco Space
Nov 14British American Tobacco: Priced For Decline But I Think It Will Grow
Oct 02British American Tobacco: Get An 8.4% Yield Plus An Upside Catalyst
Sep 24The Long Thesis On British American Tobacco Amid The Current Tobacco Industry Backdrop
Aug 27Buy Like Buffett: British American's 9.3% Yield Is The Highest In 23 Years
Aug 188.6%-Yielding British American Tobacco: As Good As It Gets
Aug 08British American Tobacco: Free Cash Flow In Focus Ahead Of H1 Earnings, Compelling Valuation
Jul 14Is British American Tobacco A Dividend Stock To Buy, Sell, Or Hold?
Jul 07British American Tobacco Vs. Philip Morris: One Seems More Undervalued
Jun 14British American Tobacco: Buy The Blood Bath - 8.79% Income Yield
Jun 04British American Tobacco: Unwarranted Fear
May 23Organigram CEO Beena Goldenberg - Expanding Beyond Canada (Transcript)
Feb 22British American Tobacco: Best Time In 20 Years To Buy This 7.4%-Yielding Aristocrat
Feb 16Ventilation des recettes et des dépenses
Comment British American Tobacco gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 26,182 | -13,878 | 3,842 | 0 |
31 Mar 24 | 26,733 | -14,145 | 3,849 | 0 |
31 Dec 23 | 27,283 | -14,412 | 3,856 | 0 |
30 Sep 23 | 27,755 | -2,847 | 3,896 | 0 |
30 Jun 23 | 28,227 | 8,718 | 3,938 | 0 |
31 Mar 23 | 27,941 | 7,668 | 3,884 | 0 |
31 Dec 22 | 27,655 | 6,617 | 3,829 | 0 |
30 Sep 22 | 27,017 | 5,996 | 3,813 | 0 |
30 Jun 22 | 26,378 | 5,375 | 3,796 | 0 |
31 Mar 22 | 26,031 | 6,082 | 3,802 | 0 |
31 Dec 21 | 25,684 | 6,789 | 3,808 | 0 |
30 Sep 21 | 25,682 | 6,491 | 3,794 | 0 |
30 Jun 21 | 25,680 | 6,193 | 3,780 | 0 |
31 Mar 21 | 25,728 | 6,297 | 3,770 | 0 |
31 Dec 20 | 25,776 | 6,400 | 3,760 | 0 |
30 Sep 20 | 25,877 | 6,374 | 3,237 | 0 |
30 Jun 20 | 25,978 | 6,347 | 2,713 | 0 |
31 Mar 20 | 25,928 | 6,026 | 2,794 | 0 |
31 Dec 19 | 25,877 | 5,704 | 2,874 | 0 |
30 Sep 19 | 25,452 | 5,930 | 2,967 | 0 |
30 Jun 19 | 25,026 | 6,156 | 3,060 | 0 |
31 Mar 19 | 24,759 | 6,094 | 3,030 | 0 |
31 Dec 18 | 24,492 | 6,032 | 3,000 | 0 |
30 Sep 18 | 24,137 | 21,973 | 2,946 | 0 |
30 Jun 18 | 23,782 | 37,914 | 2,891 | 0 |
31 Mar 18 | 21,673 | 37,700 | 2,752 | 0 |
31 Dec 17 | 19,564 | 37,485 | 2,612 | 0 |
30 Sep 17 | 17,222 | 20,862 | 2,425 | 0 |
30 Jun 17 | 15,500 | 4,238 | 2,237 | 0 |
31 Mar 17 | 15,126 | 4,443 | 2,171 | 0 |
31 Dec 16 | 14,130 | 4,648 | 2,105 | 0 |
30 Sep 16 | 13,185 | 4,482 | 2,057 | 0 |
30 Jun 16 | 13,375 | 4,316 | 2,008 | 0 |
31 Mar 16 | 13,240 | 4,303 | 1,980 | 0 |
31 Dec 15 | 12,536 | 4,290 | 1,952 | 0 |
30 Sep 15 | 13,338 | 4,152 | 1,977 | 0 |
30 Jun 15 | 13,571 | 4,013 | 2,001 | 0 |
31 Mar 15 | 13,771 | 3,564 | 2,035 | 0 |
31 Dec 14 | 13,971 | 3,115 | 2,068 | 0 |
30 Sep 14 | 14,229 | 3,363 | 2,147 | 0 |
30 Jun 14 | 14,486 | 3,611 | 2,225 | 0 |
31 Mar 14 | 14,873 | 3,758 | 2,294 | 0 |
31 Dec 13 | 15,260 | 3,904 | 2,363 | 0 |
Des revenus de qualité: BTI n'est actuellement pas rentable.
Augmentation de la marge bénéficiaire: BTI n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: BTI n'est pas rentable et les pertes ont augmenté au cours des 5 dernières années à un rythme de 41.4% par an.
Accélération de la croissance: Impossible de comparer la croissance des bénéfices de BTI au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable
Bénéfices par rapport au secteur d'activité: BTI n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Tobacco ( 2.4% ).
Rendement des fonds propres
ROE élevé: BTI a un retour sur capitaux propres négatif ( -25.09% ), car il n'est actuellement pas rentable.